What is Praxis Precision Medicines 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-26), Praxis Precision Medicines's 12-1 Month Momentum % is 221.64%.
The industry rank for Praxis Precision Medicines's 12-1 Month Momentum % or its related term are showing as below:
PRAX's 12-1 Month Momentum % is ranked better than 98.04% of 1477
companies
in the Biotechnology industry
Industry Median: -25.71
vs PRAX: 221.64
Competitive Comparison of Praxis Precision Medicines's 12-1 Month Momentum %
For the Biotechnology subindustry, Praxis Precision Medicines's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Praxis Precision Medicines's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Praxis Precision Medicines's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Praxis Precision Medicines's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Praxis Precision Medicines 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Praxis Precision Medicines's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Praxis Precision Medicines (Praxis Precision Medicines) Business Description
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRAX has been successfully added to your